For HFpEF, the RELAX trial [15] did not demonstrate a benefit of PDE5 inhibition with sildenafil, and similar results were reported for patients with a normal ejection fraction following an uncomplicated myocardial infarction [16]. This evidence concerns the gene PDE5A and myocardial infarction.